Related references
Note: Only part of the references are listed.Bone health in cancer patients: ESMO Clinical Practice Guidelines
R. Coleman et al.
ANNALS OF ONCOLOGY (2014)
Involvement of Spinal Chemokine CCL2 in the Hyperalgesia Evoked by Bone Cancer in Mice: A Role for Astroglia and Microglia
Marta Pevida et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2014)
Therapeutic opportunities for castration-resistant prostate cancer patients with bone metastases
Fable Zustovich et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2014)
NFκB-mediated CXCL1 production in spinal cord astrocytes contributes to the maintenance of bone cancer pain in mice
Jie Xu et al.
JOURNAL OF NEUROINFLAMMATION (2014)
THE CHEMOKINE CCL5 INDUCES CCR1-MEDIATED HYPERALGESIA IN MICE INOCULATED WITH NCTC 2472 TUMORAL CELLS
M. Pevida et al.
NEUROSCIENCE (2014)
International Union of Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors
Francoise Bachelerie et al.
PHARMACOLOGICAL REVIEWS (2014)
Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation
Kouji Izumi et al.
EMBO MOLECULAR MEDICINE (2013)
Analgesic effects of the non-nitrogen-containing bisphosphonates etidronate and clodronate, independent of anti-resorptive effects on bone
Siyoung Kim et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer
Kenneth J. Pienta et al.
INVESTIGATIONAL NEW DRUGS (2013)
Cancer-induced bone pain: Mechanisms and models
A. N. Lozano-Ondoua et al.
NEUROSCIENCE LETTERS (2013)
Animal models of bone cancer pain: Systematic review and meta-analyses
Gillian L. Currie et al.
PAIN (2013)
Optimization and characterization of a rat model of prostate cancer-induced bone pain using behavioral, pharmacological, radiological, histological and immunohistochemical methods
Arjun Muralidharan et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2013)
Pathobiology and management of prostate cancer-induced bone pain: recent insights and future treatments
Arjun Muralidharan et al.
INFLAMMOPHARMACOLOGY (2013)
Potentiation of acute morphine-induced analgesia measured by a thermal test in bone cancer-bearing mice
Sara Gonzalez-Rodriguez et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2012)
Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions
Isabelle Soerjomataram et al.
LANCET (2012)
CCL2 released at tumoral level contributes to the hyperalgesia evoked by intratibial inoculation of NCTC 2472 but not B16-F10 cells in mice
Marta Pevida et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2012)
TRPV1 in GABAergic Interneurons Mediates Neuropathic Mechanical Allodynia and Disinhibition of the Nociceptive Circuitry in the Spinal Cord
Yong Ho Kim et al.
NEURON (2012)
Involvement of spinal monocyte chemoattractant protein-1 (MCP-1) in cancer-induced bone pain in rats
Ji-Hua Hu et al.
NEUROSCIENCE LETTERS (2012)
Intravenous Injection of Leconotide, an Omega Conotoxin: Synergistic Antihyperalgesic Effects with Morphine in a Rat Model of Bone Cancer Pain
Anton Kolosov et al.
PAIN MEDICINE (2011)
Predominant Expression of CCL2 at the Tumor Site of Prostate Cancer Patients Directs a Selective Loss of Immunological Tolerance to CCL2 That Could Be Amplified in a Beneficial Manner
Liat Izhak et al.
JOURNAL OF IMMUNOLOGY (2010)
Implications of Bone Metastases and the Benefits of Bone-Targeted Therapy
Allan Lipton
SEMINARS IN ONCOLOGY (2010)
Chemokines and pain mechanisms
Catherine Abbadie et al.
BRAIN RESEARCH REVIEWS (2009)
Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone
Yi Lu et al.
CLINICAL & EXPERIMENTAL METASTASIS (2009)
Differential activation of spinal cord glial cells in murine models of neuropathic and cancer pain
Andreas Hald et al.
EUROPEAN JOURNAL OF PAIN (2009)
A Novel Model of Bone-Metastatic Prostate Cancer in Immunocompetent Mice
Carl A. Power et al.
PROSTATE (2009)
Intraosseous injection of RM1 murine prostate cancer cells promotes rapid osteolysis and periosteal bone deposition
N. Patrick McCabe et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
Minodronic acid, a third-generation bisphosphonate, antagonizes purinergic P2X2/3 receptor function and exerts an analgesic effect in pain models
Shuichiro Kakimoto et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Intravenous ibandronate rapidly reduces pain, neurochemical indices of central sensitization, tumor burden, and skeletal destruction in a mouse model of bone cancer
Kyle G. Halvorson et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2008)
Acidic microenvironment created by osteoclasts causes bone pain associated with tumor colonization
Maho Nagae et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2007)
Osteoclasts play a part in pain due to the inflammation adjacent to bone
Maho Nagae et al.
BONE (2006)
Spinal glial activation in a new rat model of bone cancer pain produced by prostate cancer cell inoculation of the tibia
RX Zhang et al.
PAIN (2005)
Mechanisms of disease: Mechanisms of bone metastasis
GD Roodman
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Disease modifying and anti-nociceptive effects of the bisphosphonate, zoledronic acid in a model of bone cancer pain
K Walker et al.
PAIN (2002)
Derivation of MPR and TRAMP models of prostate cancer and prostate cancer metastasis for evaluation of therapeutic strategies
DJ Voeks et al.
UROLOGIC ONCOLOGY (2002)
Enhanced therapeutic effect of HSV-tk plus GCV gene therapy and ionizing radiation for prostate cancer
M Chhikara et al.
MOLECULAR THERAPY (2001)
Share Paper
